Profile
Frans C.
Strassen is currently a Director at HMGene, Inc. He was previously the President & Chief Executive Officer at ProScript, Inc.
Frans C. Strassen active positions
| Companies | Position | Start |
|---|---|---|
HMGene, Inc.
 HMGene, Inc. Pharmaceuticals: OtherHealth Technology HMGene, Inc. provides medical services. The company was founded on April 7, 2006 and is headquartered in North Brunswick, NJ. | Director/Board Member | - |
Former positions of Frans C. Strassen
| Companies | Position | End |
|---|---|---|
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
HMGene, Inc.
HMGene, Inc. Pharmaceuticals: OtherHealth Technology HMGene, Inc. provides medical services. The company was founded on April 7, 2006 and is headquartered in North Brunswick, NJ. | Health Technology |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
- Stock Market
- Insiders
- Frans C. Strassen
